In contrast, there were no significant associations between GREB1 and MITF expression and age, sex, lymph node metastasis, melanoma subtypes, BRAF mutations, or stages (Supplementary Fig. S5A and Table 1). Here, MITF is linked to metastatic malignant neoplasm in the lymph nodes.